These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 12851699

  • 1. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y, Yamaura A, Sakiyama S, Sato Y, Tagawa M.
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [Abstract] [Full Text] [Related]

  • 2. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.
    Iwadate Y, Yamaura A, Sato Y, Sakiyama S, Tagawa M.
    Cancer Res; 2001 Dec 15; 61(24):8769-74. PubMed ID: 11751397
    [Abstract] [Full Text] [Related]

  • 3. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.
    Okada H, Villa L, Attanucci J, Erff M, Fellows WK, Lotze MT, Pollack IF, Chambers WH.
    Gene Ther; 2001 Aug 15; 8(15):1157-66. PubMed ID: 11509946
    [Abstract] [Full Text] [Related]

  • 4. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM, Okada H, Brissette-Storkus CS, Villa LA, Attanucci J, Lotze MT, Pollack IF, Bozik ME, Chambers WH.
    Cancer Res; 2000 May 01; 60(9):2449-57. PubMed ID: 10811123
    [Abstract] [Full Text] [Related]

  • 5. Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.
    Iwadate Y, Tagawa M, Namba H, Oga M, Kawamura K, Tasaki K, Sakiyama S, Yamaura A.
    Cancer Gene Ther; 2000 Sep 01; 7(9):1263-9. PubMed ID: 11023199
    [Abstract] [Full Text] [Related]

  • 6. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 01; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 7. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
    Okada H, Attanucci J, Giezeman-Smits KM, Brissette-Storkus C, Fellows WK, Gambotto A, Pollack LF, Pogue-Geile K, Lotze MT, Bozik ME, Chambers WH.
    Cancer Res; 2001 Mar 15; 61(6):2625-31. PubMed ID: 11289140
    [Abstract] [Full Text] [Related]

  • 8. Granulocyte macrophage-colony stimulating factor gene transfer to induce a protective anti-tumoral immune response against the 9L rat gliosarcoma model.
    Lefranc F, Cool V, Velu T, Brotchi J, De Witte O.
    Int J Oncol; 2002 May 15; 20(5):1077-85. PubMed ID: 11956607
    [Abstract] [Full Text] [Related]

  • 9. Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model.
    Lumniczky K, Desaknai S, Mangel L, Szende B, Hamada H, Hidvegi EJ, Safrany G.
    Cancer Gene Ther; 2002 Jan 15; 9(1):44-52. PubMed ID: 11916244
    [Abstract] [Full Text] [Related]

  • 10. Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine.
    Okada H, Giezeman-Smits KM, Tahara H, Attanucci J, Fellows WK, Lotze MT, Chambers WH, Bozik ME.
    Gene Ther; 1999 Feb 15; 6(2):219-26. PubMed ID: 10435106
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-12-mediated induction of systemic immunity in the periphery and recruitment of activated T cells into the brain produce limited antitumor effects compared with interleukin-2.
    Iwadate Y, Namba H, Sakiyama S, Yamaura A, Tagawa M.
    Int J Mol Med; 2002 Dec 15; 10(6):741-7. PubMed ID: 12430001
    [Abstract] [Full Text] [Related]

  • 12. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH, Chen Y, Chang CJ, Tai KF, Lin SM, Hwang LH.
    Clin Cancer Res; 2005 Feb 15; 11(4):1639-49. PubMed ID: 15746069
    [Abstract] [Full Text] [Related]

  • 13. Induced immunity by expression of interleukin-2 or GM-CSF gene in murine neuroblastoma cells can generate antitumor response to established tumors.
    Yoshida H, Tanabe M, Miyauchi M, Kawamura K, Takenaga K, Ohnuma N, Sakiyama S, Tagawa M.
    Cancer Gene Ther; 1999 Feb 15; 6(5):395-401. PubMed ID: 10505849
    [Abstract] [Full Text] [Related]

  • 14. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA, McLean CS, Boursnell ME, Martin G, Holmes CL, Reeder S, Entwisle C, Blakeley DM, Shields JG, Todryk S, Vile R, Robins RA, Rees RC.
    Cancer Res; 2000 Mar 15; 60(6):1663-70. PubMed ID: 10749137
    [Abstract] [Full Text] [Related]

  • 15. Vaccination for experimental gliomas using GM-CSF-transduced glioma cells.
    Herrlinger U, Kramm CM, Johnston KM, Louis DN, Finkelstein D, Reznikoff G, Dranoff G, Breakefield XO, Yu JS.
    Cancer Gene Ther; 1997 Mar 15; 4(6):345-52. PubMed ID: 9408604
    [Abstract] [Full Text] [Related]

  • 16. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y, Kono T, Yasumoto R, Kishimoto T, Wang CY, Haas GP, Nishisaka N.
    J Immunother; 2001 Mar 15; 24(3):205-11. PubMed ID: 11394497
    [Abstract] [Full Text] [Related]

  • 17. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.
    Wakimoto H, Abe J, Tsunoda R, Aoyagi M, Hirakawa K, Hamada H.
    Cancer Res; 1996 Apr 15; 56(8):1828-33. PubMed ID: 8620500
    [Abstract] [Full Text] [Related]

  • 18. Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene.
    Benedetti S, Bruzzone MG, Pollo B, DiMeco F, Magrassi L, Pirola B, Cirenei N, Colombo MP, Finocchiaro G.
    Cancer Res; 1999 Feb 01; 59(3):645-52. PubMed ID: 9973213
    [Abstract] [Full Text] [Related]

  • 19. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
    Sandler AD, Chihara H, Kobayashi G, Zhu X, Miller MA, Scott DL, Krieg AM.
    Cancer Res; 2003 Jan 15; 63(2):394-9. PubMed ID: 12543793
    [Abstract] [Full Text] [Related]

  • 20. Regression of orthotopic brain tumors by cytokine-assisted tumor vaccines primed in the brain.
    Tseng SH, Hsieh CL, Lin SM, Hwang LH.
    Cancer Gene Ther; 1999 Jan 15; 6(4):302-12. PubMed ID: 10419048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.